Zomepirac (sodium salt)

Zomepirac sodium salt (McN-2783-21-98) is a potent prostaglandin biosynthesis inhibitor. Zomepirac sodium salt is a non-steroidal anti-inflammatory drug (NSAID) . Zomepirac sodium salt can cause immune-mediated liver injury[1][2].

Product Specifications

CAS Number

[64092-48-4]

Product Name Alternative

McN-2783-21-98

UNSPSC

12352005

Hazard Statement

H300, H311+H331

Target

PGE synthase

Type

Reference compound

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/Zomepirac-sodium-salt.html

Purity

99.63

Solubility

DMSO : 100 mg/mL (ultrasonic) |H2O : 5 mg/mL (ultrasonic)

Smiles

O=C(O[Na])CC1=CC(C)=C(C(C2=CC=C(Cl)C=C2)=O)N1C

Molecular Formula

C15H13ClNNaO3

Molecular Weight

313.71

Precautions

H300, H311+H331

References & Citations

[1]Min Wang, et al. Hepatic covalent adduct formation with zomepirac in the CD26-deficient mouse. J Gastroenterol Hepatol. 2002 Jan;17 (1) :66-71.|[2]T P Pruss, et al. Evaluation of the analgesic properties of zomepirac. J Clin Pharmacol. 1980 Apr;20 (4) :216-22.